From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

With limited treatment options and potential for admission to the intensive care unit, researchers of a new paper highlighted ...

Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions. The ...

In the U.S., new cases of pulmonary fibrosis have been increasing in recent years and patients hospitalized for severe COVID-19 may be at particular risk, according to the researchers.

The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...

Objective Radiotherapy (RT) can cause a range of negative impacts in addition to the intended treatment impacts. Pulmonary rehabilitation (PR) may improve the physical and psychological conditions of ...

The right treatment for a pulmonary embolism depends on the size of the blood clot, complications you might be experiencing, and your risk of future blood clots. Options may include medications or ...

With the acquisition, Merck gets access to Verona Pharma's chronic obstructive pulmonary disease medication Ohtuvayre. The Food and Drug Administration approved Ohtuvayre in June 2024 for the ...